Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PharmaCyte Biotech, Inc.

  • LAS VEGAS, Nevada
  • Public · NASDAQ: PMCB
  • 2 employees
$7.5MMarket cap
$0Revenue · FY2025
$30.7MNet income
2Employees
PMCBNASDAQ
2003IPO

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$0
Net income
$30.7M
Total assets
$55.2M
Market cap
$7.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PMCB

15-minute delayed · data by Polygon.io

Market cap
$7.5M
Open
Day range
Prev close
Volume
IPO date
Sep 11, 2003

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review PharmaCyte Biotech, Inc..

Write a review
Explore

Similar companies

Browse all →